A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adult Subjects with Neuromyelitis Optica Spectrum Disorders–Top line efficacy and safety results (Plen02.001)
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.92.15_supplement.plen02.001